Australia markets closed
  • ALL ORDS

    7,266.30
    +151.80 (+2.13%)
     
  • ASX 200

    6,988.10
    +149.80 (+2.19%)
     
  • AUD/USD

    0.7040
    +0.0007 (+0.10%)
     
  • OIL

    87.17
    +0.56 (+0.65%)
     
  • GOLD

    1,797.30
    +4.20 (+0.23%)
     
  • BTC-AUD

    53,101.09
    +1,650.35 (+3.21%)
     
  • CMC Crypto 200

    847.94
    +28.43 (+3.47%)
     
  • AUD/EUR

    0.6309
    +0.0001 (+0.01%)
     
  • AUD/NZD

    1.0691
    +0.0010 (+0.09%)
     
  • NZX 50

    11,852.15
    -198.17 (-1.64%)
     
  • NASDAQ

    14,003.11
    -169.65 (-1.20%)
     
  • FTSE

    7,554.31
    +84.53 (+1.13%)
     
  • Dow Jones

    34,160.78
    -7.31 (-0.02%)
     
  • DAX

    15,524.27
    +64.88 (+0.42%)
     
  • Hang Seng

    23,606.01
    -200.99 (-0.84%)
     
  • NIKKEI 225

    26,717.34
    +547.04 (+2.09%)
     

AI Drug Discovery and Design Global Market Insights 2021, Featuring Relay Therapeutics, Schrodinger, PathAI, Cellarity and Atomwise - ResearchAndMarkets.com

·2-min read

DUBLIN, December 03, 2021--(BUSINESS WIRE)--The "AI Drug Discovery and Design Global Market Insights 2021, Analysis and Forecast to 2026, by Market Participants, Regions, Technology, Application" report has been added to ResearchAndMarkets.com's offering.

This report describes the global market size of AI Drug Discovery and Design from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026.

For the geography segment, regional supply, demand, major players, price is presented from 2016 to 2026.

This report covers the following regions:

  • North America

  • South America

  • Asia & Pacific

  • Europe

  • MEA

The key countries for each region are also included such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of AI Drug Discovery and Design as well as some small players.

Companies Covered:

  • Relay Therapeutics

  • AbCellera

  • Schrodinger

  • Recursion Pharmaceuticals

  • PathAI

  • Insitro

  • Valo Health

  • Cellarity

  • XtalPi

  • BenevolentAI

  • Datavant

  • Atomwise

  • Exscientia Ltd

The information for each competitor includes:

  • Company Profile

  • Business Information

  • SWOT Analysis

  • Revenue, Gross Margin and Market Share

Types Segment:

  • Precision Target

  • Precision Design

  • Precision Experiment

  • Precision Medicine

Base Year: 2021

Historical Data: from 2016 to 2020

Forecast Data: from 2021 to 2026

For more information about this report visit https://www.researchandmarkets.com/r/k069mc

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211203005506/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting